Dotmatics Names Michael Swartz as Chief Strategy Officer
Dotmatics has appointed Michael Swartz, a pioneer in digital transformation of life sciences R&D labs and former Senior VP of Enterprise Product Strategy involved in developing the Dotmatics Luma® Scientific Intelligence Platform, as Chief Strategy Officer to lead long-term strategic initiatives enhancing the company's AI-powered scientific software solutions that unify and analyze complex R&D data for improved decision-making.
BOSTON, MA - August 22, 2024 – Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, announced the appointment of Michael Swartz as Chief Strategy Officer, reporting to CEO Thomas Swalla. Previously, Swartz was Senior Vice President of Enterprise Product Strategy and was closely involved in the development of Dotmatics Luma®, a Scientific Intelligence Platform.
Swartz was an early pioneer in the digital transformation of today’s life sciences R&D labs. He will play a vital role in driving Dotmatics’ long-term strategic initiatives to continue to enhance the company’s value to its customers.
Dotmatics provides solutions to scientists that improve the speed and efficiency of the R&D process. It recently introduced Luma®, the first multimodal Scientific Intelligence Platform to help scientists unify workflows and dataflows and analyze diverse data at scale for better decision-making. Built on Databricks, Dotmatics Luma helps researchers pull data into the platform from scientific applications, databases, and lab instruments—an important development for scientists who typically struggle with critical data trapped in silos. Luma can handle both the volume and complexity of data at a nearly exponential scale, and it’s built to do so in an intuitive way that scientists can easily manage.
“Michael’s experience over the past 25 years allows him to understand our customers' challenges with extreme empathy,” said Thomas Swalla, Chief Executive Officer of Dotmatics. “He deeply understands science and software and his extensive experience marrying these two into transformative solutions will be crucial as he partners with our product teams and our broader organization to combine our mission-critical applications together with Luma to drive an AI-powered Lab-in-a-Loop for our customers.”
Prior to joining Dotmatics, Michael was the Vice President of Software Solutions and Strategy at PerkinElmer Informatics (Revvity), where he led strategic planning and execution for the overall product portfolio including the Signals platform, ChemDraw, and Spotfire. Michael has also served as Vice President of Knowledge Management at CambridgeSoft, a pioneer in the Electronic Lab Notebook market.
“I joined Dotmatics at a transformational moment in our industry. The advancements in AI/ML and accelerated computing alongside the various new modalities of therapeutics will have an enormous positive impact on our industry and our society,” said Swartz. "It’s not very often in a career that you can see such concrete progress toward such a goal in such a short time frame. But Dotmatics has built and acquired best-in-class scientific applications that are key components of scientist and researcher multimodal workflows and we’re now unifying those with Luma to power AI discovery in science.”
About Dotmatics
Dotmatics is a leader in R&D scientific software connecting science, data, and decision-making. Its enterprise R&D platform and scientists’ favorite applications drive efficiency and accelerate innovation. More than 2 million scientists and 10,000 customers trust Dotmatics to help them create a healthier, cleaner, safer world. Dotmatics is a global team of more than 800 people dedicated to supporting its customers in over 180 countries. Dotmatics has made 14 acquisitions since 2017. The company’s principal office is in Boston, with 14 offices and R&D teams located around the world.
Dotmatics is backed by Insight Partners, a leading global venture capital and private equity firm investing in high-growth technology and software scaleup companies. Learn more about Dotmatics, its platform, and applications including GraphPad Prism, Geneious, SnapGene, Protein Metrics, and LabArchives at https://www.dotmatics.com/.
Media Contacts
Cory Edwards
Vice President, Corporate Communications
Dotmatics
media@dotmatics.com
Related
The Data Lifecycle: From Instrument Integration to Advanced Analysis
The article discusses how Dotmatics Luma™, a comprehensive scientific data platform, addresses the challenges faced by R&D teams in managing and integrating diverse, multimodal scientific data from instruments and various sources to streamline the entire data lifecycle—from ingestion and processing to advanced analysis—thereby enabling faster, AI-ready insights that accelerate innovation and research outcomes.
How Luma Lab Connect Automates Lab Data Acquisition Across 100+ Instruments
Dotmatics Luma Lab Connect, part of the Dotmatics Luma multimodal scientific R&D platform, automates and streamlines the acquisition, management, and preparation of complex, multimodal lab data from over 100 diverse instruments and sources, addressing challenges of data security, integrity, and usability to enhance research productivity and enable FAIR data practices within a unified, low-code SaaS environment.
Data Evolution in Pharma: The Spread of Multimodal
The pharmaceutical industry is shifting from single-mode to multimodal drug discovery, incorporating diverse therapeutic modalities like biologics, gene therapies, and small molecules, but this evolution presents significant challenges in integrating heterogeneous R&D data and technologies, necessitating advanced, compatible platforms to enable efficient collaboration and leverage AI-driven insights for faster, cost-effective drug development.
From Data Silos to AI-Ready Science: The Vision Behind Dotmatics Luma
Dotmatics Luma is a new, AI-driven, multimodal scientific platform designed to overcome data silos and fragmented R&D systems by uniting diverse scientific software and streamlining workflows across biologics, small molecule, and materials discovery, enabling smarter, faster, and more collaborative drug discovery and therapeutics development at the enterprise level.
Limitations of Existing Life Science Software—and the Opportunity to Evolve
Existing life science software tools like ELNs, LIMS, and SDMS, while essential for digitizing workflows and managing data, are limited by their siloed, non-real-time, and non-AI-integrated designs, presenting an opportunity to evolve by integrating them into unified, intelligent platforms—such as Dotmatics Luma—that enable connected, workflow-aware, multimodal scientific intelligence with adaptive workflows, real-time data flow, and cross-functional insights without replacing core systems.
Dotmatics introduces Luma Agent: the AI co-scientist built on structured scientific data
Dotmatics has launched Luma Agent, an AI co-scientist integrated into its Luma Scientific Intelligence Platform, which leverages structured, ontology-backed scientific data to autonomously plan, execute, and manage complex scientific workflows—including data analysis, reporting, and platform configuration—delivering fully traceable, verifiable, and reproducible results with human-approved actions to accelerate lab work from days to minutes while ensuring governance and accountability.